Researcher
Minne Casteels
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Department of Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Jan 2012 → 30 Jun 2013 - Laboratory of Peroxisome Biology and Intracellular Communication (Division)
Member
From1 Oct 2007 → 31 Dec 2011
Projects
1 - 3 of 3
- Optimalisation of pharmacotherapy and patient safety by development of advanced clinical decision support systems in hospital and first line settingFrom1 Mar 2020 → 21 Feb 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Assessment of market access policies and instruments for oncology drugs.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Role of peroxisomal alpha-oxidation and 2-hydroxyacyl-CoA lyase in the degradation of endogeneous and xenobiotic substrates.From1 Jan 2010 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 45
- Market access of cancer drugs in European countries: improving resource allocation(2014)
Authors: Kim Pauwels, Isabelle Huys, Minne Casteels, Katelijne De Nys, Steven Simoens
Pages: 95 - 110 - Markttoegang van kankergeneesmiddelen: procedures voor prijszetting en terugbetaling in Europese landen(2014)
Authors: Kim Pauwels, Isabelle Huys, Minne Casteels, Katelijne De Nys, Steven Simoens
Pages: 1 - 6 - Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis(2014)
Authors: Minne Casteels
Pages: 2071 - 82 - Call for a Dedicated European Legal Framework for Bacteriophage Therapy(2014)
Authors: Gilbert Verbeken, Rob Lavigne, Minne Casteels, Isabelle Huys
Pages: 117 - 129 - Drug shortages in European countries: a trade-off between market attractiveness and cost containment?(2014)
Authors: Kim Pauwels, Isabelle Huys, Minne Casteels, Steven Simoens
Pages: 438 - How often did Belgian physicians co-prescribe tamoxifen with strong CYP2D6 inhibitors over the last 6 years?(2014)
Authors: Anne-Sophie Dieudonné, Katelijne De Nys, Minne Casteels, Hans Wildiers, Patrick Neven
Pages: 47 - 52 - Wat met Psyche en Pillen?(2014)
Authors: Stephan Claes, Jan De Lepeleire, Minne Casteels, Marina Danckaerts, Koen Demyttenaere, Gert Laekeman, Patrick Luyten, Bart Pattyn, Philippe Persoons, Erik Schokkaert, et al.
Number of pages: 166 - Market access of cancer drugs in European countries: a matter of setting priorities for resource allocation(2013)
Authors: Kim Pauwels, Isabelle Huys, Katelijne De Nys, Minne Casteels, Steven Simoens
Pages: A427 - A427 - Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy(2013)
Authors: Isabelle Huys, Rob Lavigne, Minne Casteels, Gilbert Verbeken
Pages: 951 - 954 - Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine(2012)
Authors: Gilbert Verbeken, Rob Lavigne, Minne Casteels, Isabelle Huys
Pages: 161 - 172